Balance Sheet
Accounts PayablesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMYMP) Notes Payables (2016)

Bristol Myers Squibb (BMYMP) has disclosed Notes Payables for 8 consecutive years, with $155.0 million as the latest value for Q2 2016.

  • Quarterly Notes Payables fell 79.47% to $155.0 million in Q2 2016 from the year-ago period, while the trailing twelve-month figure was $155.0 million through Jun 2016, down 79.47% year-over-year, with the annual reading at $139.0 million for FY2015, 76.44% down from the prior year.
  • Notes Payables for Q2 2016 was $155.0 million at Bristol Myers Squibb, up from $106.0 million in the prior quarter.
  • The five-year high for Notes Payables was $1.4 billion in Q1 2013, with the low at $106.0 million in Q1 2016.
  • Average Notes Payables over 5 years is $494.3 million, with a median of $383.0 million recorded in 2014.
  • The sharpest move saw Notes Payables soared 846.21% in 2013, then tumbled 79.52% in 2014.
  • Over 5 years, Notes Payables stood at $826.0 million in 2012, then tumbled by 56.54% to $359.0 million in 2013, then skyrocketed by 64.35% to $590.0 million in 2014, then crashed by 76.44% to $139.0 million in 2015, then increased by 11.51% to $155.0 million in 2016.
  • According to Business Quant data, Notes Payables over the past three periods came in at $155.0 million, $106.0 million, and $139.0 million for Q2 2016, Q1 2016, and Q4 2015 respectively.